The thymidylate synthase (TS) gene was isolated from a genomic Candida albicans library by functional complementation of a Saccharomyces cerevisiae strain deficient in TS. The gene was localized on a 4-kilobase HindIll DNA fragment and was shown to be expressed in a Thy-strain of Escherichia coi. The Thymidylate synthase (TS) has been characterized from a wide variety of organisms and is a proven target in cancer chemotherapy (25) . TS should be a good chemotherapeutic target in Candida albicans, a common fungal pathogen, since the product of the enzyme, dTMP, can only be synthesized de novo in yeasts; they lack thymidine kinase and are impermeable to thymine, thymidine, and dTMP (6). Effective inhibition of TS in yeasts would result in death, since these organisms are unable to produce their own dTMP or obtain it from the environment. 5-Fluorocytosine inhibits C. albicans and several other fungi both in vitro and in vivo (3). Furthermore, treatment of C. albicans with 5-fluorocytosine (9) results in 5-fluoro-dUMP accumulation and inhibition of TS, thus implicating this enzyme as a chemotherapeutic target in fungi.
The thymidylate synthase (TS) gene was isolated from a genomic Candida albicans library by functional complementation of a Saccharomyces cerevisiae strain deficient in TS. The gene was localized on a 4-kilobase HindIll DNA fragment and was shown to be expressed in a Thy-strain of Escherichia coi. The nucleotide sequence of the TS gene predicted a protein of 315 amino acids with a molecular weight of 36,027. The gene was cloned into a T7 expression vector in E. coi, allowing purification of large amounts of C. albicans TS. It was also purified from a wild-type C. albicans strain. Comparison of several enzyme properties including analysis of amino-terminal amino acid sequences showed the native and cloned C. albicans TS to be the same.
Thymidylate synthase (TS) has been characterized from a wide variety of organisms and is a proven target in cancer chemotherapy (25) . TS should be a good chemotherapeutic target in Candida albicans, a common fungal pathogen, since the product of the enzyme, dTMP, can only be synthesized de novo in yeasts; they lack thymidine kinase and are impermeable to thymine, thymidine, and dTMP (6) . Effective inhibition of TS in yeasts would result in death, since these organisms are unable to produce their own dTMP or obtain it from the environment. 5-Fluorocytosine inhibits C. albicans and several other fungi both in vitro and in vivo (3) . Furthermore, treatment of C. albicans with 5-fluorocytosine (9) results in 5-fluoro-dUMP accumulation and inhibition of TS, thus implicating this enzyme as a chemotherapeutic target in fungi.
Information obtained from the characterization of target enzymes in vitro has contributed to the design of new potential chemotherapeutic agents. Such studies are facilitated by the availability of large quantities of pure enzyme. Since low levels of TS are present in cultures of C. albicans, the cloning and overexpression of C. albicans TS in Escherichia coli was undertaken. We report the isolation of the C. albicans TS gene by functional complementation of a Saccharomyces cerevisiae strain deficient in TS. The gene was sequenced with about 400 base pairs (bp) of DNA 5' to the gene and a short 3'-flanking region and expressed in E. coli by using a T7 expression vector. The purified enzyme from both C. albicans and E. coli was prepared, and its properties were examined to ensure that the cloned TS enzyme as expressed in E. coli was identical to the native TS enzyme of C. albicans.
MATERIALS AND METHODS
Strains, plasmids, and media. Table 1 contains a list of the strains used in this study. S. cerevisiae GY712, provided by Gareth R. Taylor, Mt. Sinai Research Institute, Toronto, Ontario, Canada, was grown at 34°C in YPD broth (17) supplemented with 1.5 mg of KH2PO4 per ml and 100 ,ug of dTMP per ml. This strain is Tup-and thus permeable to exogenous dTMP (35) . A genomic library prepared from C. albicans B792 (ATCC 36803) was obtained from Yigal Koltin, Tel-Aviv University, Tel Aviv, Israel. The library was prepared by ligating a Sau3A partial digest of genomic DNA, * Corresponding author. isolated as a pool of 8-to 10-kilobase-pair (kb) fragments, into the BamHI site of the low-copy-number S. cerevisiae-E. coli shuttle vector pYSK35 (Fig. 1) . The S. cerevisiae-E. coli shuttle vector YEp13 (8) was used to detect the subcloned TS in S. cerevisiae. The E. coli vector pBS+ (Stratagene Inc., La Jolla, Calif.) was used for manipulations of DNA in E. coli and for production of single-stranded DNA templates. E. coli SF34 was prepared for this study by plating DH5a on minimal plates (1.5% agar containing VogelBonner salts [32] and 0.2% glucose) with 15 ,ug of trimethoprim per ml and 70 ,ug of thymidine per ml. We assume SF34 to have a point mutation in the thyA gene; it had no detectable TS activity and required thymidine for growth. E. coli SS5507 was prepared from BL21(DE3) by insertion of a transposon into the E. coli thyA gene. E. coli were routinely grown at 37°C in YT broth (21) . Thymidylate auxotrophs were supplemented with 100 ,ug of thymidine per ml. Highlevel expression of the C. albicans TS gene was accomplished by using an expression plasmid derived from pET-3C (23 (34) .
DNA sequencing. The DNA sequence was determined by the dideoxy-chain termination method (24) with the sequencing system from Bethesda Research Laboratories. Ordered deletion subclones were made by unidirectional digestion by the method of Henikoff (13) . Exonuclease III and S1 nuclease were obtained from Bethesda Research Laboratories.
Site-directed mutagenesis. Changes in DNA sequences were accomplished using oligonucleotide-directed mutagenesis (38) . Oligonucleotides were prepared on a Biosearch 8600 DNA synthesizer.
TS assay. TS activity was determined spectrophotometrically (33) or by the tritium release assay (10 (32) , 10 g.tg of tetracycline per ml, 10 ,ug of kanamycin per ml, and 0.004% Mazu 60 P (an antifoaming agent; Mazer Chemicals, Inc., Gurnee, Ill.) in a 16-liter fermentor (New Brunswick Scientific Co., Inc., New Brunswick, N.J.) at 30°C. When the optical density of the culture at 600 nm was 1.25, the lac promoter was induced with 1.0% lactose for 4 h. The lac promoter transcribed the T7 RNA polymerase, which then transcribed the cloned C. albicans TS gene. The cells were concentrated by centrifugation and washed with 50 mM potassium phosphate (pH 7.4) containing 1 mM MgCl2. Cell pellets (100 g [wet weight]) were suspended in 200 ml of 20 mM Tris hydrochloride (pH 7.4) containing 20 ,ug of lysozyme per ml, 1 mM EDTA, 10 mM 2-ME, and 100 ,uM phenylmethylsulfonyl fluoride and frozen at -70°C. The cells were thawed at 37°C, DNase and RNase (1 mg/ml in 100 mM MgSO4) were added to a final concentration of 1 ,ug/ml, and the suspension was centrifuged at 9,000 x g for 60 min. The supernatant was retained; the pellet was suspended in the initial volume of lysis buffer, and the process was repeated. Both supernatants were combined and dialyzed overnight against 10 mM Tris hydrochloride (pH 7.4) containing 10 mM 2-ME and 100 ,uM phenylmethylsulfonyl fluoride. The dialyzed crude extract was loaded onto a Rapid Flow column (100 ml; Sepragen Corp., San Leandro, Calif.) containing Q-Sepharose (Pharmacia, Inc., Piscataway, N.J.). The column was washed with the dialysis buffer, and the protein was eluted with a 0 to 200 mM NaCl gradient in buffer. Tubes containing TS, as determined by SDS-polyacrylamide gel electrophoresis, were pooled and precipitated with 70% (NH4)2SO4. After centrifugation, the pellet was suspended in a minimal volume of water and dialyzed overnight against 50 mM potassium phosphate (pH 7.4) containing 10 mM 2-ME and 5% glycerol. The dialyzed sample was loaded onto a column (7.5 by 55 cm) containing Sephacryl S-300 (Pharmacia) and eluted with the same buffer minus glycerol. The peak tubes of enzyme activity were pooled, precipitated with 70% (NH4)2SO4, and dialyzed against 10 mM potassium phosphate (pH 7.4) containing 10 mM 2-ME and 5% glycerol. The purified protein was stored at -80°C after concentration with YM10 membranes. The purification of the C. albicans TS from E. coli is summarized in Table 2 .
DNA hybridization. Electrophoretically separated restriction digests were transferred to nitrocellulose as described by Fling et al. (12) . The filters were treated with 5 x Denhardt solution-5% SSPE (19)-0.3% (wt/vol) SDS-25% deionized formamide for 1 h at 37°C and then hybridized under the same conditions with labeled probe overnight at 37°C. Hybridized filters were washed with 2 x SSC (1x SSC is 0.15 M NaCl plus 0.015 M sodium citrate)-0.1% SDS at room temperature for 15 min, with a minimum of three changes, and then at higher temperatures (37 and 42°C) and exposed overnight to X-ray film with intensifying screens. The HindIII-EcoRI fragment of pSS92-9 was nick translated by using a nick-translation kit (Bethesda Research Laboratories) and [a-32P]dATP (>600 Ci/mmol; Du Pont, NEN Research Products, Boston, Mass.) and used as the probe.
Other procedures. Amino acid analysis was done by Dave Klapper, University of North Carolina, Chapel Hill. Samples were desalted by high-pressure liquid chromatography on a model 214 TPS C4 steel column (VYDAC, Hesperia, Calif.) with 0.1% trifluoroacetic acid and acetonitrile. The amino acid sequence analysis was performed on a model 470A gas phase sequencer (Applied Biosystems, Foster City, Calif.) with in-line high-pressure liquid chromatography analysis. Amino acid analysis was performed by highpressure liquid chromatography analysis of phenylisothiocyanate derivatives (14) .
Protein concentrations were determined by the Coomassie blue method (27) or by the method of Lowry et al. (18) with bovine serum albumin as the standard.
SDS-polyacrylamide gel electrophoresis was done by the method of Laemmli (16) with 12% polyacrylamide gels. The purity of TS was estimated by using a model 2190 laser densitometer (LKB) and the Gelscan Program version 2190 (LKB) after staining and destaining the gels.
RESULTS AND DISCUSSION
Isolation of the C. albicans TS gene. S. cerevisiae GY712, which requires dTMP for growth, was transformed with a pYSK35 C. albicans genomic library, selecting directly for the ability to grow in the absence of dTMP. One transformant, containing plasmid pSS9-3, grew in the absence of exogenous dTMP, indicating the presence of a functional TS gene product.
pSS9-3 contains about 14 kb of C. albicans genomic DNA. A partial restriction map was determined (Fig. 1) , and the three HindIII fragments were individually subcloned by ligation of a HindIII digest of pSS9-3 to HindlIl-digested pBS+ and HindlIl-digested YEp13. To ascertain whether any of these plasmids contained an intact TS gene, the plasmids derived from YEp13 were transformed into GY712 and selected for the relief of the dTMP auxotrophy. One HindIII fragment, when present in YEp13, was sufficient to relieve the dTMP auxotrophy of GY712. This 4-kb HindIII fragment was also cloned in both orientations in pBS+ (Fig.  1, pSS65-2 and pSS92-9 ). An E. coli strain lacking a functional TS gene, SF34, was transformed to ampicillin resistance with pSS65-2 and pSS92-9. SF34(pSS65-2) and SF34(pSS92-9) were tested for their ability to grow without (31) .
Sequencing and features of the C. albicans TS gene. Using ordered deletions prepared from pSS65-2 and pSS92-9, we determined the DNA sequence for 1,413 bp of the 4-kb fragment of C. albicans DNA (Fig. 2) . The initiation codon for C. albicans TS was found at position 413 and was followed by an opening reading frame of 948 bp encoding 315 amino acids with a predicted molecular weight of 36,027. The predicted molecular weight agreed with the observed molecular weight of the native protein (34,500) determined by SDS-polyacrylamide gel electrophoresis. The G+C content of the sequenced region, 33.2%, was in good agreement with the 35.1% G+C content that has been calculated for C. albicans (28) . Codon usage showed a very strong preference for A or T in position 3. The position 3 preference for A or T was stronger in the C. albicans TS gene (77.7%) than in the S. cerevisiae TS gene (67.2%) (31) or in 64 other S. cerevisiae genes (61.3%) (20) .
About 400 bp of DNA 5' to the TS gene was sequenced (Fig. 2) . This DNA might be expected to contain transcriptional and translational signals for the expression of the gene. Control of the expression of genes in Candida species has not been as extensively studied as in S. cerevisiae and higher eucaryotes; however, it is expected that expression signals in Candida species will resemble those of S. cerevisiae and higher eucaryotes. CAAT (4) and TATA (7) boxes have been implicated in the initiation of transcription in eucaryotes. Several TATA-like sequences were present in the sequence 5' of the TS gene at positions 118, 179, and 364 (Fig. 2) . A possible CAAT box was also present as TCAAT at positions 53 to 57 (Fig. 2) . This sequence was present 67 bp upstream of the TATA box at 118. Interestingly, the same sequence is a part of the larger sequence CTCAATTGA at positions 52 to 60 (Fig. 2) , which is also found 5' of the C. albicans dihydrofolate reductase gene and is similarly spaced from an upstream TATA box (C. Richards, unpublished results). Many yeast mRNAs from S. cerevisiae have sequences that are complementary to the 3' terminus of S. cerevisiae 18S ribosomes and that may enhance the efficiency by which ribosomes bind to the mRNA (36 Fig. 1 ) was used to probe genomic DNAs of C. albicans, S. cerevisiae, and E. coli. The probe hybridized only with the genomic DNA of C. albicans under the conditions used (42°C; see Materials and Methods). The probe, however, did not always hybridize to the fragment of C. albicans genomic DNA that was predicted by the restriction map of pSS9-3 (data not shown). Apparently, at least two Sau3A fragments were ligated into pYSK35 to form pSS9-3 and thus the 14 kb of C. albicans DNA in pSS9-3 is not contiguous in the Candida genome. These discrepancies between the restriction map of pSS9-3 and Candida genomic DNA were found for HindIII and EcoRI restriction digests but not for an EcoRI-Clal double restriction digest. The probe does hybridize as expected to the 1.8-kb ClaI-EcoRI fragment of genomic Candida DNA. As determined by DNA sequencing, this fragment contains more than 75% of the TS gene, and there are no Sau3A sites between the EcoRI site in the TS gene and the end of the gene. A further verification that the TS gene was isolated intact and unrearranged is the extensive similarity between the S. cerevisiae (31) and C. albicans genes throughout the entire coding sequence, including the 3' end (66.5% identity from the EcoRI site to the 3' end).
Expression of Candida TS in E. coli. The T7 expression system described by Studier and Moffat (29) was used to overproduce the C. albicans TS gene product in E. coli. Briefly, this system exploits the specificity of T7 RNA polymerase for its own unique promoters. The gene to be expressed is cloned immediately 3' to a T7 RNA polymerase promoter. In the absence of T7 RNA polymerase, this gene will not be transcribed. However, in the presence of T7 RNA polymerase, the gene will be very actively transcribed. E. coli SS5507, derived from BL21(DE3) (29) , is a A lysogen carrying the RNA polymerase gene from T7 under the control of the inducible E. coli lac promoter such that in the absence of inducer, little or no T7 RNA polymerase is made by the cell. SS5507 would yield preparations of Candida TS that are not contaminated with E. coli TS since the bacterial TS gene is interrupted by a transposon.
The T7 expression plasmid, pTX1927, is a modified version of pET-3C (23) . Briefly, the BglII-EcoRV region of pET-3C containing the T7 promoter that precedes gene 10 in T7 DNA and a T7 transcription terminator was modified to contain new cloning sites 3' to the T7 RNA polymerase promoter such that genes to be expressed could be inserted as EcoRI-SstI fragments (Fig. 3) . The T7 promoter and T7 transcription terminator of pET-3C are unchanged. Other salient points of the plasmid are its high copy number and its ability to be maintained with tetracycline selection.
Placement of restriction sites before and after the gene was necessary to transfer the C. albicans TS gene into the expression plasmid. Oligonucleotide-directed mutagenesis was used to specifically insert an EcoRI (GAATTC) site after nucleotide position 414 and an SstI (GAGCTC) site after position 1377 ( Fig. 1 and 2) . Also, the adenine residue found at position 1149 was changed to a guanine, eliminating an EcoRI site in the gene while retaining the Glu codon. With these changes made, the TS gene was removed from pSS177-57 (Fig. 1) as an EcoRI-SstI fragment, ligated into the expression plasmid to yield pTX1927 (Fig. 3) , and transformed into E. coli SS5507. When the T7 RNA polymerase is supplied by a chromosomal lysogen under lac control, small amounts of T7 RNA polymerase will be made even under repressed conditions (29) . This is apparently the case for SS5507, since uninduced cultures of SS5507(pTX1927) produce sufficient TS to eliminate the need for exogenous thymidine. Under optimally induced conditions, this strain contains approximately 20% of its soluble cellular protein as TS. This is less than that reported for this system (29) and may be due to the use in the C. albicans gene of codons that corresponded to rare tRNAs in E. coli.
Purification and properties of TS. TS was purified from wild-type C. albicans ATCC 11651 by gel filtration and affinity chromatography (Table 2 ) to a specific activity of 3,325 U/mg of protein. C. albicans TS expressed in E. coli SS5507(pTX1927) was purified to a specific activity of 3,724 U/mg, of protein by ion-exchange chromatography and gel filtration ( Table 2 ). Both preparations were >95% pure as judged by SDS-polyacrylamide gel electrophoresis. The purified cloned enzyme which was concentrated by ultrafiltration lost activity during this procedure. However, once concentrated, the enzyme could be stored without further loss of activity (at least 6 months) at -80°C in 20 mM potassium phosphate buffer (pH 7.5) containing 20 mM 2-ME and 20% glycerol.
Amino-terminal amino acid analysis of the enzyme purified from C. albicans revealed the amino-terminal sequence of Thr-Val-Ser-Pro-Asn-Thr-Ala-Glu-Gln-Ala-Tyr-Leu-AspLeu-XXX-Lys-Arg-Ile-Ile-Asp-Glu-Gly.... This exactly matched the first seven amino-terminal residues of the cloned enzyme expressed in E. coli. Both sources yielded TS protein that had had its amino-terminal methionine removed.
Kinetic characteristics of C. albicans TS prepared from C. albicans and E. coli varied less than twofold and were well within the ranges found for T$ from other sources (25) . The apparent Km for dUMP (using 200 ,uM [6R,S]-5,10-CH2-H4 pteroylglutamate as the cosubstrate) was 2.5 ,uM for the enzyme produced in C. albicans and 3.1 FM for the enzyme produced in E. coli. The apparent Km for [6R,S]-5,10-CH2-H4pteroylglutamate was 38.4 ,uM for the enzyme prepared from C. albicans and 46.2 F.M for the enzyme prepared from E. coli. In TS from many other sources (25) Hanlon, and R. Tansik for technical assistance.
ADDENDUM IN PROOF
The nucleotide sequence data reported here will appear in the GenBank nucleotide sequence data base under the accession number J04230.
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